{"table_id": "table2-1756286419843447", "table_label": "Table 2.", "table_caption": "Demographic, clinical and neuropsychological characteristics of all patients. Demographic, clinical, and neuropsychological characteristics of the total PD sample, cognitively normal (PD-N), mildly cognitively impaired (PD-MCI), demented patients (PD-D), and healthy controls. Data are given as mean \u00b1 standard deviation (min\u2013max) except for sex.", "table_foot": "\u2020CERAD total score is the sum of six subscores\u2021and is sociodemographically corrected for normative data including age, education, and sex.15\u2021CERAD scores are given as z scores.*Unpaired two-sample Student\u2019s t test for unequal variances for continuous variables and Chi-square test for categorical variables.+Kruskal\u2013Wallis analysis of variance on ranks for PD-N, PD-MCI, PD-D and healthy controls for continuous variables and Chi-square test for categorical variables.CERAD, Consortium to Establish a Registry for Alzheimer\u2019s Disease; F, female; LEDD, levodopa-equivalent daily dose; M, male; MMSE, mini mental state examination; NA, not available/not applicable; PANDA, Parkinson neuropsychometric dementia assessment;13 PD, Parkinson\u2019s disease; PD-D, patients with PD-associated dementia; PD-MCI, mildly cognitively impaired PD patients; PD-N, patients with PD with normal cognition; UPDRS, unified Parkinson\u2019s disease rating scale.", "n_header_rows": 1, "table_data_file": "table_001.csv"}